Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature
Conclusions
To our knowledge, this is the first report of a patient with metastatic mesenteric leiomyosarcoma who is in complete clinical and radiological long-term remission following very aggressive multimodal treatment; including intense poly-drug chemotherapy and without any demonstrable long-term side effects. Given the rarity of mesenteric leiomyosarcoma and lack of guidelines regarding oncological therapy, we suggest that multimodal therapy including aggressive chemotherapy, guided by a multidisciplinary team, is essential to achieve an optimal outcome.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Leiomyosarcoma | Liver | Palliative | Palliative Care | Sarcomas | Urology & Nephrology